Heart Regeneration and Repair: Molecular Mechanism and Therapeutic Targets

Abstract

The substantial loss of cardiomyocytes resulting from myocardial infarction leads to pathological remodeling of the heart and the onset of heart failure. Promoting heart regeneration is therefore a critical therapeutic goal for repairing damaged cardiac tissue. Over the past two decades, the utilization of cardiac stem cells for heart regeneration has emerged as a focal point of research. However, the related mechanisms and efficacy remain constrained by poor integration and survival. Concurrently, genetic lineage tracing has definitively shown that the adult mammalian heart lacks significant endogenous stem cells. It is now widely accepted that heart regeneration primarily arises from the proliferation of pre-existing adult cardiomyocytes. This review systematically summarizes the physiological and microenvironmental changes during the developmental process of cardiomyocytes, elucidates the intrinsic and extrinsic molecular biological mechanisms that regulate cardiomyocyte proliferation, and discusses exogenous cell transplantation therapy, potentially endogenous pharmacological and genetic approaches, as well as promising bioengineering and cross-disciplinary methods. By synthesizing these multifaceted advances, this review aims to clarify important issues that require further elucidation in this field, thereby advancing the depth of research on heart regeneration and its clinical translational applications.

Keywords

cardiomyocyte proliferation / heart regeneration / metabolic reprogramming / myocardial infarction / therapeutics

References

[1] G. Savarese, P. M. Becher, L. H. Lund, et al., “Global Burden of Heart Failure: A Comprehensive and Updated Review of Epidemiology,” Cardiovascular Research 118, no. 17 (2023): 3272-3287.

[2] S. S. Virani, A. Alonso, E. J. Benjamin, et al., “Heart Disease and Stroke Statistics-2020 Update: A Report from the American Heart Association,” Circulation 141, no. 9 (2020): e139-e596.

[3] Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet 392, no. 10159 (2018): 1789-1858.

[4] J. Feng, Y. Zhang, and J. Zhang, “Epidemiology and Burden of Heart Failure in Asia,” JACC Asia 4, no. 4 (2024): 249-264.

[5] H. Wang, Y. Li, K. Chai, et al., “Mortality in Patients Admitted to Hospital With Heart Failure in China: A Nationwide Cardiovascular Association Database-Heart Failure Centre Registry Cohort Study,” The Lancet Global Health 12, no. 4 (2024): e611-e622.

[6] Q. Guo, J. Yang, X. Feng, and Y. Zhou, “Regeneration of the Heart: From Molecular Mechanisms to Clinical Therapeutics,” Military Medical Research 10, no. 1 (2023): 18.

[7] T. Eschenhagen, R. Bolli, T. Braun, et al., “Cardiomyocyte Regeneration: A Consensus Statement,” Circulation 136, no. 7 (2017): 680-686.

[8] E. R. Porrello, A. I. Mahmoud, E. Simpson, et al., “Transient Regenerative Potential of the Neonatal Mouse Heart,” Science 331, no. 6020 (2011): 1078-1080.

[9] B. Z. Stanger, “Cellular Homeostasis and Repair in the Mammalian Liver,” Annual Review of Physiology 77 (2015): 179-200.

[10] A. P. Beltrami, L. Barlucchi, D. Torella, et al., “Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration,” Cell 114, no. 6 (2003): 763-776.

[11] D. Orlic, J. Kajstura, S. Chimenti, et al., “Bone Marrow Cells Regenerate Infarcted Myocardium,” Nature 410, no. 6829 (2001): 701-705.

[12] T. L. Rasmussen, G. Raveendran, J. Zhang, and D. J. Garry, “Getting to the Heart of Myocardial Stem Cells and Cell Therapy,” Circulation 123, no. 16 (2011): 1771-1779.

[13] Y. Shiba, T. Gomibuchi, T. Seto, et al., “Allogeneic Transplantation of iPS Cell-derived Cardiomyocytes Regenerates Primate Hearts,” Nature 538, no. 7625 (2016): 388-391.

[14] S. R. Ali, S. Hippenmeyer, L. V. Saadat, et al., “Existing Cardiomyocytes Generate Cardiomyocytes at a Low Rate After Birth in Mice,” PNAS 111, no. 24 (2014): 8850-8855.

[15] C. Jopling, E. Sleep, M. Raya, et al., “Zebrafish Heart Regeneration Occurs by Cardiomyocyte Dedifferentiation and Proliferation,” Nature 464, no. 7288 (2010): 606-609.

[16] O. Bergmann, R. D. Bhardwaj, S. Bernard, et al., “Evidence for Cardiomyocyte Renewal in Humans,” Science 324, no. 5923 (2009): 98-102.

[17] L. He, M. Han, Z. Zhang, et al., “Reassessment of c-Kit(+) Cells for Cardiomyocyte Contribution in Adult Heart,” Circulation 140, no. 2 (2019): 164-166.

[18] W. Zhu, E. Zhang, M. Zhao, et al., “Regenerative Potential of Neonatal Porcine Hearts,” Circulation 138, no. 24 (2018): 2809-2816.

[19] [Experts' consensus on Mammalian Cardiomyocyte Regeneration]. Sheng Li Xue Bao [Acta Physiologica Sinica] 76, no. 2 (2024): 175-214.

[20] J. C. Garbern and R. T. Lee, “Heart Regeneration: 20 Years of Progress and Renewed Optimism,” Developmental Cell 57, no. 4 (2022): 424-439.

[21] L. He, N. B. Nguyen, R. Ardehali, and B. Zhou, “Heart Regeneration by Endogenous Stem Cells and Cardiomyocyte Proliferation: Controversy, Fallacy, and Progress,” Circulation 142, no. 3 (2020): 275-291.

[22] F. Li, X. Wang, J. M. Capasso, and A. M. Gerdes, “Rapid Transition of Cardiac Myocytes From Hyperplasia to Hypertrophy During Postnatal Development,” Journal of Molecular and Cellular Cardiology 28, no. 8 (1996): 1737-1746.

[23] S. D. Lundy, W. Z. Zhu, M. Regnier, and M. A. Laflamme, “Structural and Functional Maturation of Cardiomyocytes Derived From human Pluripotent Stem Cells,” Stem Cells and Development 22, no. 14 (2013): 1991-2002.

[24] A. M. Gerdes, S. E. Kellerman, J. A. Moore, et al., “Structural Remodeling of Cardiac Myocytes in Patients With Ischemic Cardiomyopathy,” Circulation 86, no. 2 (1992): 426-430.

[25] C. Kane, L. Couch, and C. M. Terracciano, “Excitation-contraction Coupling of human Induced Pluripotent Stem Cell-derived Cardiomyocytes,” Frontiers in Cell and Developmental Biology 3 (2015): 59.

[26] J. T. Hinson, A. Chopra, N. Nafissi, et al., “HEART DISEASE. Titin Mutations in iPS Cells Define Sarcomere Insufficiency as a Cause of Dilated Cardiomyopathy,” Science 349, no. 6251 (2015): 982-986.

[27] J. Satin, I. Itzhaki, S. Rapoport, et al., “Calcium Handling in human Embryonic Stem Cell-derived Cardiomyocytes,” Stem Cells 26, no. 8 (2008): 1961-1972.

[28] V. Mahdavi, A. M. Lompre, A. P. Chambers, and B. Nadal-Ginard, “Cardiac Myosin Heavy Chain Isozymic Transitions During Development and Under Pathological Conditions Are Regulated at the Level of mRNA Availability,” European Heart Journal 5, no. Suppl F (1984): 181-191.

[29] X. Yuan and T. Braun, “Multimodal Regulation of Cardiac Myocyte Proliferation,” Circulation Research 121, no. 3 (2017): 293-309.

[30] J. Liu, Z. Laksman, and P. H. Backx, “The Electrophysiological Development of Cardiomyocytes,” Advanced Drug Delivery Reviews 96 (2016): 253-273.

[31] E. Carmeliet, “Pacemaking in Cardiac Tissue. From IK2 to a Coupled-clock System,” Physiological Reports 7, no. 1 (2019): e13862.

[32] Z. Zhao, H. Lan, I. El-Battrawy, et al., “Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes,” Stem Cells International 2018 (2018): 6067096.

[33] C. Schmid, N. Abi-Gerges, M. G. Leitner, D. Zellner, and G. Rast, “Ion Channel Expression and Electrophysiology of Singular Human (Primary and Induced Pluripotent Stem Cell-Derived) Cardiomyocytes,” Cells 10, no. 12 (2021): 3370.

[34] E. Karbassi, A. Fenix, S. Marchiano, et al., “Cardiomyocyte Maturation: Advances in Knowledge and Implications for Regenerative Medicine,” Nature Reviews Cardiology 17, no. 6 (2020): 341-359.

[35] B. N. Puente, W. Kimura, S. A. Muralidhar, et al., “The Oxygen-rich Postnatal Environment Induces Cardiomyocyte Cell-cycle Arrest Through DNA Damage Response,” Cell 157, no. 3 (2014): 565-579.

[36] G. Maroli and T. Braun, “The Long and Winding Road of Cardiomyocyte Maturation,” Cardiovascular Research 117, no. 3 (2021): 712-726.

[37] T. Oka, V. H. Lam, L. Zhang, et al., “Cardiac Hypertrophy in the Newborn Delays the Maturation of Fatty Acid Beta-oxidation and Compromises Postischemic Functional Recovery,” American Journal of Physiology. Heart and Circulatory Physiology 302, no. 9 (2012): H1784-H1794.

[38] D. Zhang, J. Ning, T. Ramprasath, et al., “Kynurenine Promotes Neonatal Heart Regeneration by Stimulating Cardiomyocyte Proliferation and Cardiac Angiogenesis,” Nature Communications 13, no. 1 (2022): 6371.

[39] J. W. Miklas, S. Levy, P. Hofsteen, et al., “Amino Acid Primed mTOR Activity Is Essential for Heart Regeneration,” Iscience 25, no. 1 (2022): 103574.

[40] M. M. Lalowski, S. Bjork, P. Finckenberg, et al., “Characterizing the Key Metabolic Pathways of the Neonatal Mouse Heart Using a Quantitative Combinatorial Omics Approach,” Frontiers in Physiology 9 (2018): 365.

[41] X. Chen, H. Wu, Y. Liu, et al., “Metabolic Reprogramming: A Byproduct or a Driver of Cardiomyocyte Proliferation?,” Circulation 149, no. 20 (2024): 1598-1610.

[42] X. Li, F. Wu, S. Gunther, et al., “Inhibition of Fatty Acid Oxidation Enables Heart Regeneration in Adult Mice,” Nature 622, no. 7983 (2023): 619-626.

[43] W. Derks and O. Bergmann, “Polyploidy in Cardiomyocytes: Roadblock to Heart Regeneration?,” Circulation Research 126, no. 4 (2020): 552-565.

[44] M. Leone, G. Musa, and F. B. Engel, “Cardiomyocyte Binucleation Is Associated With Aberrant Mitotic Microtubule Distribution, Mislocalization of RhoA and IQGAP3, as Well as Defective Actomyosin Ring Anchorage and Cleavage Furrow Ingression,” Cardiovascular Research 114, no. 8 (2018): 1115-1131.

[45] T. Mohamed, Y. S. Ang, E. Radzinsky, et al., “Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration,” Cell 173, no. 1 (2018): 104-116. e12.

[46] S. E. Senyo, M. L. Steinhauser, C. L. Pizzimenti, et al., “Mammalian Heart Renewal by Pre-existing Cardiomyocytes,” Nature 493, no. 7432 (2013): 433-436.

[47] Z. Yao, L. Bai, K. Dou, and Y. Nie, “Identifying Cardiomyocyte Ploidy with Nuclear Area and Volume,” Circulation 149, no. 19 (2024): 1540-1542.

[48] M. H. Soonpaa, G. Y. Koh, L. Pajak, et al., “Cyclin D1 Overexpression Promotes Cardiomyocyte DNA Synthesis and Multinucleation in Transgenic Mice,” Journal of Clinical Investigation 99, no. 11 (1997): 2644-2654.

[49] V. Khori, Z. F. Mohammad, B. Tavakoli-Far, et al., “Role of Oxytocin and c-Myc Pathway in Cardiac Remodeling in Neonatal Rats Undergoing Cardiac Apical Resection,” European Journal of Pharmacology 908 (2021): 174348.

[50] D. C. Zebrowski, R. Becker, and F. B. Engel, “Towards Regenerating the Mammalian Heart: Challenges in Evaluating Experimentally Induced Adult Mammalian Cardiomyocyte Proliferation,” American Journal of Physiology. Heart and Circulatory Physiology 310, no. 9 (2016): H1045-H1054.

[51] K. B. Pasumarthi, H. Nakajima, H. O. Nakajima, M. H. Soonpaa, and L. J. Field, “Targeted Expression of Cyclin D2 Results in Cardiomyocyte DNA Synthesis and Infarct Regression in Transgenic Mice,” Circulation Research 96, no. 1 (2005): 110-118.

[52] G. D. Lopaschuk and J. S. Jaswal, “Energy Metabolic Phenotype of the Cardiomyocyte During Development, Differentiation, and Postnatal Maturation,” Journal of Cardiovascular Pharmacology 56, no. 2 (2010): 130-140.

[53] J. C. Garbern and R. T. Lee, “Mitochondria and Metabolic Transitions in Cardiomyocytes: Lessons From Development for Stem Cell-derived Cardiomyocytes,” Stem Cell Research & Therapy 12, no. 1 (2021): 177.

[54] Y. Li, M. Yang, J. Tan, et al., “Targeting ACSL1 Promotes Cardiomyocyte Proliferation and Cardiac Regeneration,” Life Sciences 294 (2022): 120371.

[55] A. Magadum, N. Singh, A. A. Kurian, et al., “Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration,” Circulation 141, no. 15 (2020): 1249-1265.

[56] V. M. Fajardo, I. Feng, B. Y. Chen, et al., “GLUT1 overexpression Enhances Glucose Metabolism and Promotes Neonatal Heart Regeneration,” Scientific Reports 11, no. 1 (2021): 8669.

[57] Y. Chen, G. Wu, M. Li, et al., “LDHA-mediated Metabolic Reprogramming Promoted Cardiomyocyte Proliferation by Alleviating ROS and Inducing M2 Macrophage Polarization,” Redox Biology 56 (2022): 102446.

[58] A. C. Cardoso, N. T. Lam, J. J. Savla, et al., “Mitochondrial Substrate Utilization Regulates Cardiomyocyte Cell Cycle Progression,” Nature Metabolism 2, no. 2 (2020): 167-178.

[59] T. Cao, D. Liccardo, R. LaCanna, et al., “Fatty Acid Oxidation Promotes Cardiomyocyte Proliferation Rate but Does Not Change Cardiomyocyte Number in Infant Mice,” Frontiers in Cell and Developmental Biology 7 (2019): 42.

[60] Y. A. Hannun and L. M. Obeid, “Sphingolipids and Their Metabolism in Physiology and Disease,” Nature Reviews Molecular Cell Biology 19, no. 3 (2018): 175-191.

[61] X. Ji, Z. Chen, Q. Wang, et al., “Sphingolipid Metabolism Controls Mammalian Heart Regeneration,” Cell Metabolism 36, no. 4 (2024): 839-856. e8.

[62] D. Chong, Y. Gu, T. Zhang, et al., “Neonatal Ketone Body Elevation Regulates Postnatal Heart Development by Promoting Cardiomyocyte Mitochondrial Maturation and Metabolic Reprogramming,” Cell Discovery 8, no. 1 (2022): 106.

[63] Y. Y. Cheng, Z. Gregorich, R. P. Prajnamitra, et al., “Metabolic Changes Associated with Cardiomyocyte Dedifferentiation Enable Adult Mammalian Cardiac Regeneration,” Circulation 146, no. 25 (2022): 1950-1967.

[64] V. Talman, J. Teppo, P. Poho, et al., “Molecular Atlas of Postnatal Mouse Heart Development,” Journal of the American Heart Association 7, no. 20 (2018): e010378.

[65] Y. Huang, M. Zhou, H. Sun, and Y. Wang, “Branched-chain Amino Acid Metabolism in Heart Disease: An Epiphenomenon or a Real Culprit?,” Cardiovascular Research 90, no. 2 (2011): 220-223.

[66] C. Peet, A. Ivetic, D. I. Bromage, and A. M. Shah, “Cardiac Monocytes and Macrophages After Myocardial Infarction,” Cardiovascular Research 116, no. 6 (2020): 1101-1112.

[67] C. Han, Y. Nie, H. Lian, et al., “Acute Inflammation Stimulates a Regenerative Response in the Neonatal Mouse Heart,” Cell Research 25, no. 10 (2015): 1137-1151.

[68] Y. Ma, “Role of Neutrophils in Cardiac Injury and Repair Following Myocardial Infarction,” Cells 10, no. 7 (2021): 1676.

[69] I. Kologrivova, M. Shtatolkina, T. Suslova, and V. Ryabov, “Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair after Myocardial Infarction,” Frontiers in Immunology 12 (2021): 664457.

[70] M. N. Daseke, U. Chalise, M. Becirovic-Agic, et al., “Neutrophil Signaling During Myocardial Infarction Wound Repair,” Cell Signalling 77 (2021): 109816.

[71] K. Jiang, Z. Tu, K. Chen, et al., “Gasdermin D Inhibition Confers Antineutrophil-mediated Cardioprotection in Acute Myocardial Infarction,” Journal of Clinical Investigation 132, no. 1 (2022): e151268.

[72] I. Andreadou, H. A. Cabrera-Fuentes, Y. Devaux, et al., “Immune Cells as Targets for Cardioprotection: New Players and Novel Therapeutic Opportunities,” Cardiovascular Research 115, no. 7 (2019): 1117-1130.

[73] A. B. Aurora, E. R. Porrello, W. Tan, et al., “Macrophages Are Required for Neonatal Heart Regeneration,” Journal of Clinical Investigation 124, no. 3 (2014): 1382-1392.

[74] D. A. Ferenbach, T. A. Sheldrake, K. Dhaliwal, et al., “Macrophage/Monocyte Depletion by Clodronate, but Not Diphtheria Toxin, Improves Renal Ischemia/Reperfusion Injury in Mice,” Kidney International 82, no. 8 (2012): 928-933.

[75] K. J. Lavine, S. Epelman, K. Uchida, et al., “Distinct Macrophage Lineages Contribute to Disparate Patterns of Cardiac Recovery and Remodeling in the Neonatal and Adult Heart,” PNAS 111, no. 45 (2014): 16029-16034.

[76] Y. Li, J. Feng, S. Song, et al., “gp130 Controls Cardiomyocyte Proliferation and Heart Regeneration,” Circulation 142, no. 10 (2020): 967-982.

[77] S. Zacchigna, V. Martinelli, S. Moimas, et al., “Paracrine Effect of Regulatory T Cells Promotes Cardiomyocyte Proliferation During Pregnancy and After Myocardial Infarction,” Nature Communications 9, no. 1 (2018): 2432.

[78] J. Li, K. Y. Yang, R. Tam, et al., “Regulatory T-cells Regulate Neonatal Heart Regeneration by Potentiating Cardiomyocyte Proliferation in a Paracrine Manner,” Theranostics 9, no. 15 (2019): 4324-4341.

[79] K. Klaourakis, J. M. Vieira, and P. R. Riley, “The Evolving Cardiac Lymphatic Vasculature in Development, Repair and Regeneration,” Nature Reviews Cardiology 18, no. 5 (2021): 368-379.

[80] D. Gancz, B. C. Raftrey, G. Perlmoter, et al., “Distinct Origins and Molecular Mechanisms Contribute to Lymphatic Formation During Cardiac Growth and Regeneration,” Elife 8 (2019): e44153.

[81] X. Liu, E. De la Cruz, X. Gu, et al., “Lymphoangiocrine Signals Promote Cardiac Growth and Repair,” Nature 588, no. 7839 (2020): 705-711.

[82] Y. Tan, X. Duan, B. Wang, X. Liu, and Z. Zhan, “Murine Neonatal Cardiac B Cells Promote Cardiomyocyte Proliferation and Heart Regeneration,” npj Regenerative Medicine 8, no. 1 (2023): 7.

[83] A. J. Kattoor, N. Pothineni, D. Palagiri, and J. L. Mehta, “Oxidative Stress in Atherosclerosis,” Current Atherosclerosis Reports 19, no. 11 (2017): 42.

[84] Y. J. Suzuki and N. V. Shults, “Antioxidant Regulation of Cell Reprogramming,” Antioxidants (Basel) 8, no. 8 (2019): 323.

[85] C. Rampon, M. Volovitch, A. Joliot, and S. Vriz, “Hydrogen Peroxide and Redox Regulation of Developments,” Antioxidants (Basel) 7, no. 11 (2018): 159.

[86] P. M. Rindler, S. M. Plafker, L. I. Szweda, and M. Kinter, “High Dietary Fat Selectively Increases Catalase Expression Within Cardiac Mitochondria,” Journal of Biological Chemistry 288, no. 3 (2013): 1979-1990.

[87] E. L. Seifert, C. Estey, J. Y. Xuan, and M. Harper, “Electron Transport Chain-dependent and -independent Mechanisms of Mitochondrial H2O2 Emission During Long-chain Fatty Acid Oxidation,” Journal of Biological Chemistry 285, no. 8 (2010): 5748-5758.

[88] G. Tao, P. C. Kahr, Y. Morikawa, et al., “Pitx2 promotes Heart Repair by Activating the Antioxidant Response After Cardiac Injury,” Nature 534, no. 7605 (2016): 119-123.

[89] A. Ghelli Luserna Di Rora', I. Iacobucci, and G. Martinelli, “The Cell Cycle Checkpoint Inhibitors in the Treatment of Leukemias,” Journal of Hematology & Oncology 10, no. 1 (2017): 77.

[90] J. Wen, Y. Hu, Q. Liu, et al., “miR-424 Coordinates Multilayered Regulation of Cell Cycle Progression to Promote Esophageal Squamous Cell Carcinoma Cell Proliferation,” EBioMedicine 37 (2018): 110-124.

[91] M. Krajewska, A. M. Heijink, Y. Bisselink, et al., “Forced Activation of Cdk1 via wee1 Inhibition Impairs Homologous Recombination,” Oncogene 32, no. 24 (2013): 3001-3008.

[92] M. Cui, A. Atmanli, M. G. Morales, et al., “Nrf1 promotes Heart Regeneration and Repair by Regulating Proteostasis and Redox Balance,” Nature Communications 12, no. 1 (2021): 5270.

[93] J. Krishnan, P. Ahuja, S. Bodenmann, et al., “Essential Role of Developmentally Activated Hypoxia-inducible Factor 1alpha for Cardiac Morphogenesis and Function,” Circulation Research 103, no. 10 (2008): 1139-1146.

[94] A. Sayed, S. Turoczi, F. Soares-da-Silva, et al., “Hypoxia Promotes a Perinatal-Like Progenitor state in the Adult Murine Epicardium,” Scientific Reports 12, no. 1 (2022): 9250.

[95] Y. Nakada, D. C. Canseco, S. Thet, et al., “Hypoxia Induces Heart Regeneration in Adult Mice,” Nature 541, no. 7636 (2017): 222-227.

[96] M. T. Neary, K. Ng, M. H. R. Ludtmann, et al., “Hypoxia Signaling Controls Postnatal Changes in Cardiac Mitochondrial Morphology and Function,” Journal of Molecular and Cellular Cardiology 74, no. 100 (2014): 340-352.

[97] M. Cui, Z. Wang, K. Chen, et al., “Dynamic Transcriptional Responses to Injury of Regenerative and Non-regenerative Cardiomyocytes Revealed by Single-Nucleus RNA Sequencing,” Developmental Cell 53, no. 1 (2020): 102-116. e8.

[98] T. Vu, D. Lorizio, R. Vuerich, et al., “Extracellular Matrix-Based Approaches in Cardiac Regeneration: Challenges and Opportunities,” International Journal of Molecular Sciences 23, no. 24 (2022): 15783.

[99] A. C. Silva, C. Pereira, A. Fonseca, P. Pinto-do-O, and D. S. Nascimento, “Bearing My Heart: The Role of Extracellular Matrix on Cardiac Development, Homeostasis, and Injury Response,” Frontiers in Cell and Developmental Biology 8 (2020): 621644.

[100] J. Feng, Y. Li, Y. Li, et al., “Versican Promotes Cardiomyocyte Proliferation and Cardiac Repair,” Circulation 149, no. 13 (2024): 1004-1015.

[101] H. Jiang, L. Bai, S. Song, et al., “EZH2 controls Epicardial Cell Migration During Heart Development,” Life Science Alliance 6, no. 6 (2023): 202201765.

[102] C. C. Wu, S. Jeratsch, J. Graumann, and D. Stainier, “Modulation of Mammalian Cardiomyocyte Cytokinesis by the Extracellular Matrix,” Circulation Research 127, no. 7 (2020): 896-907.

[103] C. Williams, K. P. Quinn, I. Georgakoudi, and L. R. Black, “Young Developmental Age Cardiac Extracellular Matrix Promotes the Expansion of Neonatal Cardiomyocytes in Vitro,” Acta Biomaterialia 10, no. 1 (2014): 194-204.

[104] N. Mittal, S. H. Yoon, H. Enomoto, et al., “Versican Is Crucial for the Initiation of Cardiovascular Lumen Development in medaka (Oryzias latipes),” Scientific Reports 9, no. 1 (2019): 9475.

[105] A. Baehr, K. B. Umansky, E. Bassat, et al., “Agrin Promotes Coordinated Therapeutic Processes Leading to Improved Cardiac Repair in Pigs,” Circulation 142, no. 9 (2020): 868-881.

[106] Z. Chen, J. Xie, H. Hao, et al., “Ablation of Periostin Inhibits Post-infarction Myocardial Regeneration in Neonatal Mice Mediated by the Phosphatidylinositol 3 Kinase/Glycogen Synthase Kinase 3beta/Cyclin D1 Signalling Pathway,” Cardiovascular Research 113, no. 6 (2017): 620-632.

[107] H. W. Jackson, V. Defamie, P. Waterhouse, and R. Khokha, “TIMPs: Versatile Extracellular Regulators in Cancer,” Nature Reviews Cancer 17, no. 1 (2017): 38-53.

[108] C. Sanchez-Fernandez, L. Rodriguez-Outeirino, L. Matias-Valiente, et al., “Understanding Epicardial Cell Heterogeneity During Cardiogenesis and Heart Regeneration,” Journal of Cardiovascular Development and Disease 10, no. 9 (2023): 376.

[109] Y. Xia, S. Duca, B. Perder, et al., “Activation of a Transient Progenitor state in the Epicardium Is Required for Zebrafish Heart Regeneration,” Nature Communications 13, no. 1 (2022): 7704.

[110] A. D. Theocharis, S. S. Skandalis, C. Gialeli, and N. K. Karamanos, “Extracellular Matrix Structure,” Advanced Drug Delivery Reviews 97 (2016): 4-27.

[111] A. M. Barnes, T. B. Holmstoen, A. J. Bonham, and T. J. Rowland, “Differentiating Human Pluripotent Stem Cells to Cardiomyocytes Using Purified Extracellular Matrix Proteins,” Bioengineering (Basel) 9, no. 12 (2022): 720.

[112] J. Zhang, Z. R. Gregorich, R. Tao, et al., “Cardiac Differentiation of human Pluripotent Stem Cells Using Defined Extracellular Matrix Proteins Reveals Essential Role of Fibronectin,” Elife 11 (2022): e69028.

[113] M. Notari, A. Ventura-Rubio, S. J. Bedford-Guaus, et al., “The Local Microenvironment Limits the Regenerative Potential of the Mouse Neonatal Heart,” Science Advances 4, no. 5 (2018): eaao5553.

[114] Y. Yahalom-Ronen, D. Rajchman, R. Sarig, B. Geiger, and E. Tzahor, “Reduced Matrix Rigidity Promotes Neonatal Cardiomyocyte Dedifferentiation, Proliferation and Clonal Expansion,” Elife 4 (2015): e07455.

[115] Y. P. Kong, A. Y. Rioja, X. Xue, et al., “A Systems Mechanobiology Model to Predict Cardiac Reprogramming Outcomes on Different Biomaterials,” Biomaterials 181 (2018): 280-292.

[116] P. Kong, J. Dong, W. Li, et al., “Extracellular Matrix/Glycopeptide Hybrid Hydrogel as an Immunomodulatory Niche for Endogenous Cardiac Repair After Myocardial Infarction,” Advanced science (Weinheim) 10, no. 23 (2023): e2301244.

[117] K. Huang, E. W. Ozpinar, T. Su, et al., “An off-the-shelf Artificial Cardiac Patch Improves Cardiac Repair After Myocardial Infarction in Rats and Pigs,” Science Translational Medicine 12, no. 538 (2020): eaat9683.

[118] X. He, Q. Wang, Y. Zhao, et al., “Effect of Intramyocardial Grafting Collagen Scaffold with Mesenchymal Stromal Cells in Patients with Chronic Ischemic Heart Disease: A Randomized Clinical Trial,” JAMA Network Open 3, no. 9 (2020): e2016236.

[119] P. Contessotto, R. Spelat, F. Ferro, et al., “Reproducing Extracellular Matrix Adverse Remodelling of Non-ST Myocardial Infarction in a Large Animal Model,” Nature Communications 14, no. 1 (2023): 995.

[120] J. S. Mo, H. W. Park, and K. L. Guan, “The Hippo Signaling Pathway in Stem Cell Biology and Cancer,” Embo Reports 15, no. 6 (2014): 642-656.

[121] D. Pan, “Hippo Signaling in Organ Size Control,” Genes & Development 21, no. 8 (2007): 886-897.

[122] J. Xie, Y. Wang, D. Ai, L. Yao, and H. Jiang, “The Role of the Hippo Pathway in Heart Disease,” Febs Journal 289, no. 19 (2022): 5819-5833.

[123] I. M. Moya and G. Halder, “Hippo-YAP/TAZ Signalling in Organ Regeneration and Regenerative Medicine,” Nature Reviews Molecular Cell Biology 20, no. 4 (2019): 211-226.

[124] J. Huang, S. Wu, J. Barrera, K. Matthews, and D. Pan, “The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP,” Cell 122, no. 3 (2005): 421-434.

[125] G. G. Galli, M. Carrara, W. C. Yuan, et al., “YAP Drives Growth by Controlling Transcriptional Pause Release From Dynamic Enhancers,” Molecular Cell 60, no. 2 (2015): 328-337.

[126] I. Lian, J. Kim, H. Okazawa, et al., “The Role of YAP Transcription Coactivator in Regulating Stem Cell Self-renewal and Differentiation,” Genes & Development 24, no. 11 (2010): 1106-1118.

[127] R. D. Del, Y. Yang, N. Nakano, et al., “Yes-associated Protein Isoform 1 (Yap1) Promotes Cardiomyocyte Survival and Growth to Protect Against Myocardial Ischemic Injury,” Journal of Biological Chemistry 288, no. 6 (2013): 3977-3988.

[128] A. von Gise, Z. Lin, K. Schlegelmilch, et al., “YAP1, the Nuclear Target of Hippo Signaling, Stimulates Heart Growth Through Cardiomyocyte Proliferation but Not Hypertrophy,” PNAS 109, no. 7 (2012): 2394-2399.

[129] M. Xin, Y. Kim, L. B. Sutherland, et al., “Regulation of Insulin-Like Growth Factor Signaling by Yap Governs Cardiomyocyte Proliferation and Embryonic Heart Size,” Science Signaling 4, no. 196 (2011): ra70.

[130] M. Xin, Y. Kim, L. B. Sutherland, et al., “Hippo Pathway Effector Yap Promotes Cardiac Regeneration,” PNAS 110, no. 34 (2013): 13839-13844.

[131] Z. Lin, A. von Gise, P. Zhou, et al., “Cardiac-specific YAP Activation Improves Cardiac Function and Survival in an Experimental Murine MI Model,” Circulation Research 115, no. 3 (2014): 354-363.

[132] T. O. Monroe, M. C. Hill, Y. Morikawa, et al., “YAP Partially Reprograms Chromatin Accessibility to Directly Induce Adult Cardiogenesis in Vivo,” Developmental Cell 48, no. 6 (2019): 765-779. e7.

[133] M. M. Mia, D. M. Cibi, S. Ghani, et al., “Loss of Yap/Taz in Cardiac Fibroblasts Attenuates Adverse Remodelling and Improves Cardiac Function,” Cardiovascular Research 118, no. 7 (2022): 1785-1804.

[134] A. Aharonov, A. Shakked, K. B. Umansky, et al., “ERBB2 drives YAP Activation and EMT-Like Processes During Cardiac Regeneration,” Nature Cell Biology 22, no. 11 (2020): 1346-1356.

[135] C. Torrini, R. J. Cubero, E. Dirkx, et al., “Common Regulatory Pathways Mediate Activity of MicroRNAs Inducing Cardiomyocyte Proliferation,” Cell Reports 27, no. 9 (2019): 2759-2771. e5.

[136] C. Lan, N. Cao, C. Chen, et al., “Progesterone, via Yes-associated Protein, Promotes Cardiomyocyte Proliferation and Cardiac Repair,” Cell Proliferation 53, no. 11 (2020): e12910.

[137] J. Li, E. Gao, A. Vite, et al., “Alpha-catenins Control Cardiomyocyte Proliferation by Regulating Yap Activity,” Circulation Research 116, no. 1 (2015): 70-79.

[138] M. Sakabe, M. Thompson, N. Chen, et al., “Inhibition of beta1-AR/Galphas Signaling Promotes Cardiomyocyte Proliferation in Juvenile Mice Through Activation of RhoA-YAP Axis,” Elife 11 (2022): e74576.

[139] Y. Morikawa, T. Heallen, J. Leach, Y. Xiao, and J. F. Martin, “Dystrophin-glycoprotein Complex Sequesters Yap to Inhibit Cardiomyocyte Proliferation,” Nature 547, no. 7662 (2017): 227-231.

[140] U. M. Fiuza and A. M. Arias, “Cell and Molecular Biology of Notch,” Journal of Endocrinology 194, no. 3 (2007): 459-474.

[141] S. Majumder, J. S. Crabtree, T. E. Golde, et al., “Targeting Notch in Oncology: The Path Forward,” Nature Reviews Drug Discovery 20, no. 2 (2021): 125-144.

[142] D. R. Friedmann, J. J. Wilson, and R. A. Kovall, “RAM-induced Allostery Facilitates Assembly of a Notch Pathway Active Transcription Complex,” Journal of Biological Chemistry 283, no. 21 (2008): 14781-14791.

[143] V. Fox, P. J. Gokhale, J. R. Walsh, et al., “Cell-cell Signaling Through NOTCH Regulates human Embryonic Stem Cell Proliferation,” Stem Cells 26, no. 3 (2008): 715-723.

[144] H. Li, C. Chang, X. Li, and R. Zhang, “The Roles and Activation of Endocardial Notch Signaling in Heart Regeneration,” Cell Regen 10, no. 1 (2021): 3.

[145] G. Luxan, J. C. Casanova, B. Martinez-Poveda, et al., “Mutations in the NOTCH Pathway Regulator MIB1 Cause Left Ventricular Noncompaction Cardiomyopathy,” Nature Medicine 19, no. 2 (2013): 193-201.

[146] A. Raya, C. M. Koth, D. Buscher, et al., “Activation of Notch Signaling Pathway Precedes Heart Regeneration in Zebrafish,” PNAS 100, no. Suppl 1 (2003): 11889-11895.

[147] R. Zhang, P. Han, H. Yang, et al., “In Vivo Cardiac Reprogramming Contributes to Zebrafish Heart Regeneration,” Nature 498, no. 7455 (2013): 497-501.

[148] M. Galvez-Santisteban, D. Chen, R. Zhang, et al., “Hemodynamic-mediated Endocardial Signaling Controls in Vivo Myocardial Reprogramming,” Elife 8 (2019): e44816.

[149] G. Felician, C. Collesi, M. Lusic, et al., “Epigenetic Modification at Notch Responsive Promoters Blunts Efficacy of Inducing Notch Pathway Reactivation After Myocardial Infarction,” Circulation Research 115, no. 7 (2014): 636-649.

[150] L. Zhao, A. L. Borikova, R. Ben-Yair, et al., “Notch Signaling Regulates Cardiomyocyte Proliferation During Zebrafish Heart Regeneration,” PNAS 111, no. 4 (2014): 1403-1408.

[151] K. D. Irvine, “Integration of Intercellular Signaling Through the Hippo Pathway,” Seminars in cell & developmental biology 23, no. 7 (2012): 812-817.

[152] A. Herbst, V. Jurinovic, S. Krebs, et al., “Comprehensive Analysis of Beta-catenin Target Genes in Colorectal Carcinoma Cell Lines With Deregulated Wnt/Beta-catenin Signaling,” BMC Genomics [Electronic Resource] 15 (2014): 74.

[153] T. Valenta, G. Hausmann, and K. Basler, “The Many Faces and Functions of Beta-catenin,” Embo Journal 31, no. 12 (2012): 2714-2736.

[154] K. M. Cadigan and M. L. Waterman, “TCF/LEFs and Wnt Signaling in the Nucleus,” Cold Spring Harbor perspectives in biology 4, no. 11 (2012): a007906.

[155] A. R. Moshkovsky and M. W. Kirschner, “The Nonredundant Nature of the Axin2 Regulatory Network in the Canonical Wnt Signaling Pathway,” PNAS 119, no. 9 (2022): e2108408119.

[156] D. Li, J. Sun, and T. P. Zhong, “Wnt Signaling in Heart Development and Regeneration,” Current Cardiology Reports 24, no. 10 (2022): 1425-1438.

[157] W. B. Fu, W. E. Wang, and C. Y. Zeng, “Wnt Signaling Pathways in Myocardial Infarction and the Therapeutic Effects of Wnt Pathway Inhibitors,” Acta Pharmacologica Sinica 40, no. 1 (2019): 9-12.

[158] T. T. Ni, E. J. Rellinger, A. Mukherjee, et al., “Discovering Small Molecules That Promote Cardiomyocyte Generation by Modulating Wnt Signaling,” Chemistry & Biology 18, no. 12 (2011): 1658-1668.

[159] B. Ye, N. Hou, L. Xiao, et al., “APC Controls Asymmetric Wnt/Beta-catenin Signaling and Cardiomyocyte Proliferation Gradient in the Heart,” Journal of Molecular and Cellular Cardiology 89, no. Pt B (2015): 287-296.

[160] L. Zhao, R. Ben-Yair, C. E. Burns, and C. G. Burns, “Endocardial Notch Signaling Promotes Cardiomyocyte Proliferation in the Regenerating Zebrafish Heart Through Wnt Pathway Antagonism,” Cell reports 26, no. 3 (2019): 546-554. e5.

[161] X. Peng, S. Fan, J. Tan, et al., “Wnt2bb Induces Cardiomyocyte Proliferation in Zebrafish Hearts via the jnk1/c-jun/creb1 Pathway,” Frontiers in Cell and Developmental Biology 8 (2020): 323.

[162] Y. Wu, L. Zhou, H. Liu, et al., “LRP6 downregulation Promotes Cardiomyocyte Proliferation and Heart Regeneration,” Cell Research 31, no. 4 (2021): 450-462.

[163] A. Mallick, S. Taylor, A. Ranawade, and B. P. Gupta, “Axin Family of Scaffolding Proteins in Development: Lessons From C. elegans,” Journal of Developmental Biology 7, no. 4 (2019): 20.

[164] T. Heallen, M. Zhang, J. Wang, et al., “Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size,” Science 332, no. 6028 (2011): 458-461.

[165] S. Liu, L. Tang, X. Zhao, et al., “Yap Promotes Noncanonical Wnt Signals from Cardiomyocytes for Heart Regeneration,” Circulation Research 129, no. 8 (2021): 782-797.

[166] D. Lai, X. Liu, A. Forrai, et al., “Neuregulin 1 Sustains the Gene Regulatory Network in both Trabecular and Nontrabecular Myocardium,” Circulation Research 107, no. 6 (2010): 715-727.

[167] S. J. Fuller, K. Sivarajah, and P. H. Sugden, “ErbB Receptors, Their Ligands, and the Consequences of Their Activation and Inhibition in the Myocardium,” Journal of Molecular and Cellular Cardiology 44, no. 5 (2008): 831-854.

[168] H. Kataria, A. Alizadeh, and S. Karimi-Abdolrezaee, “Neuregulin-1/ErbB Network: An Emerging Modulator of Nervous System Injury and Repair,” Progress in Neurobiology 180 (2019): 101643.

[169] J. Liu, M. Bressan, D. Hassel, et al., “A Dual Role for ErbB2 Signaling in Cardiac Trabeculation,” Development (Cambridge, England) 137, no. 22 (2010): 3867-3875.

[170] D. Meyer and C. Birchmeier, “Multiple Essential Functions of neuregulin in Development,” Nature 378, no. 6555 (1995): 386-390.

[171] M. Gassmann, F. Casagranda, D. Orioli, et al., “Aberrant Neural and Cardiac Development in Mice Lacking the ErbB4 Neuregulin Receptor,” Nature 378, no. 6555 (1995): 390-394.

[172] G. Camprecios, J. Lorita, E. Pardina, et al., “Expression, Localization, and Regulation of the Neuregulin Receptor ErbB3 in Mouse Heart,” Journal of Cellular Physiology 226, no. 2 (2011): 450-455.

[173] G. D'Uva, A. Aharonov, M. Lauriola, et al., “ERBB2 triggers Mammalian Heart Regeneration by Promoting Cardiomyocyte Dedifferentiation and Proliferation,” Nature Cell Biology 17, no. 5 (2015): 627-638.

[174] K. Bersell, S. Arab, B. Haring, and B. Kuhn, “Neuregulin1/ErbB4 signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury,” Cell 138, no. 2 (2009): 257-270.

[175] M. Gemberling, R. Karra, A. L. Dickson, and K. D. Poss, “Nrg1 is an Injury-induced Cardiomyocyte Mitogen for the Endogenous Heart Regeneration Program in zebrafish,” Elife 4 (2015): e05871.

[176] B. D. Polizzotti, B. Ganapathy, S. Walsh, et al., “Neuregulin Stimulation of Cardiomyocyte Regeneration in Mice and human Myocardium Reveals a Therapeutic Window,” Science Translational Medicine 7, no. 281 (2015): 281ra45.

[177] X. Wang, H. Wu, L. Tang, et al., “The Novel Antibody Fusion Protein rhNRG1-HER3i Promotes Heart Regeneration by Enhancing NRG1-ERBB4 Signaling Pathway,” Journal of Molecular and Cellular Cardiology 187 (2024): 26-37.

[178] H. Honkoop, D. E. de Bakker, A. Aharonov, et al., “Single-cell Analysis Uncovers That Metabolic Reprogramming by ErbB2 Signaling Is Essential for Cardiomyocyte Proliferation in the Regenerating Heart,” Elife 8 (2019): e50163.

[179] J. Grego-Bessa, L. Luna-Zurita, G. Del Monte, et al., “Notch Signaling Is Essential for Ventricular Chamber Development,” Developmental Cell 12, no. 3 (2007): 415-429.

[180] J. W. Haskins, D. X. Nguyen, and D. F. Stern, “Neuregulin 1-activated ERBB4 Interacts With YAP to Induce Hippo Pathway Target Genes and Promote Cell Migration,” Science signaling 7, no. 355 (2014): ra116.

[181] S. Artap, L. J. Manderfield, C. L. Smith, et al., “Endocardial Hippo Signaling Regulates Myocardial Growth and Cardiogenesis,” Developmental Biology 440, no. 1 (2018): 22-30.

[182] J. Chen, R. Crawford, C. Chen, and Y. Xiao, “The Key Regulatory Roles of the PI3K/Akt Signaling Pathway in the Functionalities of Mesenchymal Stem Cells and Applications in Tissue Regeneration,” Tissue Engineering Part B: Reviews 19, no. 6 (2013): 516-528.

[183] M. Li, H. Zheng, Y. Han, et al., “LncRNA Snhg1-driven Self-reinforcing Regulatory Network Promoted Cardiac Regeneration and Repair After Myocardial Infarction,” Theranostics 11, no. 19 (2021): 9397-9414.

[184] Z. Yue, J. Chen, H. Lian, et al., “PDGFR-beta Signaling Regulates Cardiomyocyte Proliferation and Myocardial Regeneration,” Cell Reports 28, no. 4 (2019): 966-978. e4.

[185] S. Chakraborty, A. Sengupta, and K. E. Yutzey, “Tbx20 promotes Cardiomyocyte Proliferation and Persistence of Fetal Characteristics in Adult Mouse Hearts,” Journal of Molecular and Cellular Cardiology 62 (2013): 203-213.

[186] W. J. Durham, Y. Li, E. Gerken, et al., “Fatiguing Exercise Reduces DNA Binding Activity of NF-kappaB in Skeletal Muscle Nuclei,” Journal of Applied Physiology (1985) 97, no. 5 (2004): 1740-1745.

[187] J. Ren and P. Anversa, “The Insulin-Like Growth Factor I System: Physiological and Pathophysiological Implication in Cardiovascular Diseases Associated With Metabolic Syndrome,” Biochemical Pharmacology 93, no. 4 (2015): 409-417.

[188] Y. Meng, J. Ding, Y. Wang, et al., “The Transcriptional Repressor Ctbp2 as a Metabolite Sensor Regulating Cardiomyocytes Proliferation and Heart Regeneration,” Molecular Medicine 31, no. 1 (2025): 119.

[189] J. Du, L. Zheng, P. Gao, et al., “A Small-molecule Cocktail Promotes Mammalian Cardiomyocyte Proliferation and Heart Regeneration,” Cell Stem Cell 29, no. 4 (2022): 545-558. e13.

[190] R. G. Li, X. Li, Y. Morikawa, et al., “YAP Induces a Neonatal-Like Pro-renewal Niche in the Adult Heart,” Nature Cardiovascular Research 3, no. 3 (2024): 283-300.

[191] D. E. Handy, R. Castro, and J. Loscalzo, “Epigenetic Modifications: Basic Mechanisms and Role in Cardiovascular Disease,” Circulation 123, no. 19 (2011): 2145-2156.

[192] L. Kraus, “Targeting Epigenetic Regulation of Cardiomyocytes Through Development for Therapeutic Cardiac Regeneration After Heart Failure,” International Journal of Molecular Sciences 23, no. 19 (2022): 11878.

[193] K. C. Abi, “The Emerging Role of Epigenetics in Cardiovascular Disease,” Therapeutic Advances in Chronic Disease 5, no. 4 (2014): 178-187.

[194] J. Cordero, A. Elsherbiny, Y. Wang, et al., “Leveraging Chromatin state Transitions for the Identification of Regulatory Networks Orchestrating Heart Regeneration,” Nucleic Acids Research 52, no. 8 (2024): 4215-4233.

[195] G. A. Quaife-Ryan, C. B. Sim, M. Ziemann, et al., “Multicellular Transcriptional Analysis of Mammalian Heart Regeneration,” Circulation 136, no. 12 (2017): 1123-1139.

[196] Z. Wang, M. Cui, A. M. Shah, et al., “Cell-Type-Specific Gene Regulatory Networks Underlying Murine Neonatal Heart Regeneration at Single-Cell Resolution,” Cell Reports 33, no. 10 (2020): 108472.

[197] Y. Dong, Y. Yang, H. Wang, et al., “Single-cell Chromatin Profiling Reveals Genetic Programs Activating Proregenerative States in Nonmyocyte Cells,” Science Advances 10, no. 8 (2024): eadk4694.

[198] D. El-Nachef, K. Oyama, Y. Y. Wu, et al., “Repressive Histone Methylation Regulates Cardiac Myocyte Cell Cycle Exit,” Journal of Molecular and Cellular Cardiology 121 (2018): 1-12.

[199] S. Ai, X. Yu, Y. Li, et al., “Divergent Requirements for EZH1 in Heart Development versus Regeneration,” Circulation Research 121, no. 2 (2017): 106-112.

[200] A. Ahmed, T. Wang, and P. Delgado-Olguin, “Ezh2 is Not Required for Cardiac Regeneration in Neonatal Mice,” PLoS ONE 13, no. 2 (2018): e0192238.

[201] R. Ben-Yair, V. L. Butty, M. Busby, et al., “H3K27me3-mediated Silencing of Structural Genes Is Required for Zebrafish Heart Regeneration,” Development (Cambridge, England) 146, no. 19 (2019): dev178632.

[202] Z. Liu, O. Chen, M. Zheng, et al., “Re-patterning of H3K27me3, H3K4me3 and DNA Methylation During Fibroblast Conversion Into Induced Cardiomyocytes,” Stem Cell Research 16, no. 2 (2016): 507-518.

[203] Z. Wang, M. Cui, A. M. Shah, et al., “Mechanistic Basis of Neonatal Heart Regeneration Revealed by Transcriptome and Histone Modification Profiling,” PNAS 116, no. 37 (2019): 18455-18465.

[204] C. Lan, C. Chen, S. Qu, et al., “Inhibition of DYRK1A, via Histone Modification, Promotes Cardiomyocyte Cell Cycle Activation and Cardiac Repair After Myocardial Infarction,” EBioMedicine 82 (2022): 104139.

[205] V. O. Rigaud, C. Zarka, J. Kurian, et al., “UCP2 modulates Cardiomyocyte Cell Cycle Activity, Acetyl-CoA, and Histone Acetylation in Response to Moderate Hypoxia,” JCI Insight 7, no. 15 (2022): e155475.

[206] P. Bashtrykov, G. Jankevicius, R. Z. Jurkowska, S. Ragozin, and A. Jeltsch, “The UHRF1 Protein Stimulates the Activity and Specificity of the Maintenance DNA Methyltransferase DNMT1 by an Allosteric Mechanism,” Journal of Biological Chemistry 289, no. 7 (2014): 4106-4415.

[207] A. Meissner, T. S. Mikkelsen, H. Gu, et al., “Genome-scale DNA Methylation Maps of Pluripotent and Differentiated Cells,” Nature 454, no. 7205 (2008): 766-770.

[208] M. Okano, S. Xie, and E. Li, “Cloning and Characterization of a family of Novel Mammalian DNA (cytosine-5) Methyltransferases,” Nature Genetics 19, no. 3 (1998): 219-220.

[209] C. Y. Kou, S. L. Lau, K. W. Au, et al., “Epigenetic Regulation of Neonatal Cardiomyocytes Differentiation,” Biochemical and Biophysical Research Communications 400, no. 2 (2010): 278-283.

[210] M. Ponnusamy, F. Liu, Y. H. Zhang, et al., “Long Noncoding RNA CPR (Cardiomyocyte Proliferation Regulator) Regulates Cardiomyocyte Proliferation and Cardiac Repair,” Circulation 139, no. 23 (2019): 2668-2684.

[211] A. Madsen, G. Hoppner, J. Krause, et al., “An Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility,” Circulation 142, no. 16 (2020): 1562-1578.

[212] V. Kmietczyk, E. Riechert, L. Kalinski, et al., “m(6)A-mRNA Methylation Regulates Cardiac Gene Expression and Cellular Growth,” Life Science Alliance 2, no. 2 (2019): e201800233.

[213] K. D. Meyer, Y. Saletore, P. Zumbo, et al., “Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3' UTRs and near Stop Codons,” Cell 149, no. 7 (2012): 1635-1646.

[214] Y. Shao, C. E. Wong, L. Shen, and H. Yu, “N(6)-methyladenosine Modification Underlies Messenger RNA Metabolism and Plant Development,” Current Opinion in Plant Biology 63 (2021): 102047.

[215] C. Liu, L. Gu, W. Deng, et al., “N6-Methyladenosine RNA Methylation in Cardiovascular Diseases,” Frontiers in Cardiovascular Medicine 9 (2022): 887838.

[216] Y. Qin, L. Li, E. Luo, et al., “Role of m6A RNA Methylation in Cardiovascular Disease (Review),” International Journal of Molecular Medicine 46, no. 6 (2020): 1958-1972.

[217] Y. Yang, S. Shen, Y. Cai, et al., “Dynamic Patterns of N6-Methyladenosine Profiles of Messenger RNA Correlated With the Cardiomyocyte Regenerability During the Early Heart Development in Mice,” Oxidative Medicine and Cellular Longevity 2021 (2021): 5537804.

[218] R. Gong, X. Wang, H. Li, et al., “Loss of M(6)A Methyltransferase METTL3 Promotes Heart Regeneration and Repair After Myocardial Injury,” Pharmacological Research 174 (2021): 105845.

[219] Z. Han, X. Wang, Z. Xu, et al., “ALKBH5 regulates Cardiomyocyte Proliferation and Heart Regeneration by Demethylating the mRNA of YTHDF1,” Theranostics 11, no. 6 (2021): 3000-3016.

[220] X. Zhang, W. Y. Zhu, S. Y. Shen, J. H. Shen, and X. D. Chen, “Biological Roles of RNA m7G Modification and Its Implications in Cancer,” Biology Direct 18, no. 1 (2023): 58.

[221] X. Xia, Y. Wang, and J. C. Zheng, “Internal m7G Methylation: A Novel Epitranscriptomic Contributor in Brain Development and Diseases,” Molecular Therapy Nucleic Acids 31 (2023): 295-308.

[222] X. Z. Chen, X. M. Li, S. J. Xu, et al., “TMEM11 regulates Cardiomyocyte Proliferation and Cardiac Repair via METTL1-mediated M(7)G Methylation of ATF5 mRNA,” Cell Death and Differentiation 30, no. 7 (2023): 1786-1798.

[223] D. Zhang, Z. Tang, H. Huang, et al., “Metabolic Regulation of Gene Expression by Histone Lactylation,” Nature 574, no. 7779 (2019): 575-580.

[224] N. Wang, W. Wang, X. Wang, et al., “Histone Lactylation Boosts Reparative Gene Activation Post-Myocardial Infarction,” Circulation Research 131, no. 11 (2022): 893-908.

[225] L. Kraus, C. Bryan, M. Wagner, et al., “Bmi1 Augments Proliferation and Survival of Cortical Bone-Derived Stem Cells After Injury Through Novel Epigenetic Signaling via Histone 3 Regulation,” International Journal of Molecular Sciences 22, no. 15 (2021): 7813.

[226] S. R. Bhaumik, E. Smith, and A. Shilatifard, “Covalent Modifications of Histones During Development and Disease Pathogenesis,” Nature structural & molecular biology 14, no. 11 (2007): 1008-1016.

[227] N. J. VanDusen, J. Y. Lee, W. Gu, et al., “Massively Parallel in Vivo CRISPR Screening Identifies RNF20/40 as Epigenetic Regulators of Cardiomyocyte Maturation,” Nature Communications 12, no. 1 (2021): 4442.

[228] J. J. Chong, X. Yang, C. W. Don, et al., “Human Embryonic-stem-cell-derived Cardiomyocytes Regenerate Non-human Primate Hearts,” Nature 510, no. 7504 (2014): 273-277.

[229] C. L. Mummery, J. Zhang, E. S. Ng, et al., “Differentiation of human Embryonic Stem Cells and Induced Pluripotent Stem Cells to Cardiomyocytes: A Methods Overview,” Circulation Research 111, no. 3 (2012): 344-358.

[230] C. Mummery, O. D. Ward-van, P. Doevendans, et al., “Differentiation of human Embryonic Stem Cells to Cardiomyocytes: Role of Coculture With Visceral Endoderm-Like Cells,” Circulation 107, no. 21 (2003): 2733-2740.

[231] Y. Shiba, S. Fernandes, W. Z. Zhu, et al., “Human ES-cell-derived Cardiomyocytes Electrically Couple and Suppress Arrhythmias in Injured Hearts,” Nature 489, no. 7415 (2012): 322-325.

[232] K. Takahashi and S. Yamanaka, “Induction of Pluripotent Stem Cells From Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors,” Cell 126, no. 4 (2006): 663-676.

[233] K. S. Rao, J. E. Kloppenburg, T. Marquis, et al., “CTGF-D4 Amplifies LRP6 Signaling to Promote Grafts of Adult Epicardial-derived Cells That Improve Cardiac Function after Myocardial Infarction,” Stem Cells 40, no. 2 (2022): 204-214.

[234] D. Wong, J. Martinez, and P. Quijada, “Exploring the Function of Epicardial Cells beyond the Surface,” Circulation Research 135, no. 2 (2024): 353-371.

[235] B. Zhou, L. B. Honor, H. He, et al., “Adult Mouse Epicardium Modulates Myocardial Injury by Secreting Paracrine Factors,” Journal of Clinical Investigation 121, no. 5 (2011): 1894-1904.

[236] B. Zhou, Q. Ma, S. Rajagopal, et al., “Epicardial Progenitors Contribute to the Cardiomyocyte Lineage in the Developing Heart,” Nature 454, no. 7200 (2008): 109-113.

[237] X. L. Luo, Y. Jiang, Q. Li, et al., “hESC-Derived Epicardial Cells Promote Repair of Infarcted Hearts in Mouse and Swine,” Advanced science (Weinheim) 10, no. 27 (2023): e2300470.

[238] E. Messina, L. De Angelis, G. Frati, et al., “Isolation and Expansion of Adult Cardiac Stem Cells From human and Murine Heart,” Circulation Research 95, no. 9 (2004): 911-921.

[239] K. Malliaras, T. S. Li, D. Luthringer, et al., “Safety and Efficacy of Allogeneic Cell Therapy in Infarcted Rats Transplanted With Mismatched Cardiosphere-derived Cells,” Circulation 125, no. 1 (2012): 100-112.

[240] R. R. Smith, L. Barile, H. C. Cho, et al., “Regenerative Potential of Cardiosphere-derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens,” Circulation 115, no. 7 (2007): 896-908.

[241] I. Chimenti, R. R. Smith, T. S. Li, et al., “Relative Roles of Direct Regeneration versus Paracrine Effects of human Cardiosphere-derived Cells Transplanted Into Infarcted Mice,” Circulation Research 106, no. 5 (2010): 971-980.

[242] V. Schachinger, S. Erbs, A. Elsasser, et al., “Intracoronary Bone Marrow-derived Progenitor Cells in Acute Myocardial Infarction,” New England Journal of Medicine 355, no. 12 (2006): 1210-1221.

[243] J. Bartunek, J. D. Croissant, W. Wijns, et al., “Pretreatment of Adult Bone Marrow Mesenchymal Stem Cells With Cardiomyogenic Growth Factors and Repair of the Chronically Infarcted Myocardium,” American Journal of Physiology. Heart and Circulatory Physiology 292, no. 2 (2007): H1095-H1104.

[244] R. Bolli, A. R. Chugh, D. D'Amario, et al., “Cardiac Stem Cells in Patients With Ischaemic Cardiomyopathy (SCIPIO): Initial Results of a Randomised Phase 1 Trial,” Lancet 378, no. 9806 (2011): 1847-1857.

[245] P. Menasche, V. Vanneaux, A. Hagege, et al., “Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction,” Journal of the American College of Cardiology 71, no. 4 (2018): 429-438.

[246] R. Romagnuolo, H. Masoudpour, A. Porta-Sanchez, et al., “Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias,” Stem Cell Reports 12, no. 5 (2019): 967-981.

[247] S. A. Fisher, C. Doree, A. Mathur, D. P. Taggart, and E. Martin-Rendon, “Stem Cell Therapy for Chronic Ischaemic Heart Disease and Congestive Heart Failure,” Cochrane Database of Systematic Reviews (Online) 12, no. 12 (2016): CD007888.

[248] M. Kawamura, S. Miyagawa, K. Miki, et al., “Feasibility, Safety, and Therapeutic Efficacy of human Induced Pluripotent Stem Cell-derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model,” Circulation 126, no. 11 Suppl 1 (2012): S29-S37.

[249] Y. Shiba, D. Filice, S. Fernandes, et al., “Electrical Integration of Human Embryonic Stem Cell-Derived Cardiomyocytes in a Guinea Pig Chronic Infarct Model,” Journal of Cardiovascular Pharmacology and Therapeutics 19, no. 4 (2014): 368-381.

[250] M. E. Hartman, D. Dai, and M. A. Laflamme, “Human Pluripotent Stem Cells: Prospects and Challenges as a Source of Cardiomyocytes for in Vitro Modeling and Cell-based Cardiac Repair,” Advanced Drug Delivery Reviews 96 (2016): 3-17.

[251] S. M. Taapken, B. S. Nisler, M. A. Newton, et al., “Karotypic Abnormalities in human Induced Pluripotent Stem Cells and Embryonic Stem Cells,” Nature Biotechnology 29, no. 4 (2011): 313-314.

[252] I. Tsai and C. Sun, “Stem Cell Therapy Against Ischemic Heart Disease,” International Journal of Molecular Sciences 25, no. 7 (2024): 3778.

[253] L. C. Liew, B. X. Ho, and B. Soh, “Mending a Broken Heart: Current Strategies and Limitations of Cell-based Therapy,” Stem Cell Research & Therapy 11, no. 1 (2020): 138.

[254] Y. Liu, R. Kamran, X. Han, et al., “Human Heart-on-a-chip Microphysiological System Comprising Endothelial Cells, Fibroblasts, and iPSC-derived Cardiomyocytes,” Scientific Reports 14, no. 1 (2024): 18063.

[255] J. Zhou, B. Cui, X. Wang, et al., “Overexpression of KCNJ2 Enhances Maturation of human-induced Pluripotent Stem Cell-derived Cardiomyocytes,” Stem Cell Research & Therapy 14, no. 1 (2023): 92.

[256] S. Wu, Y. Li, W. Huang, et al., “Paracrine Effect of CXCR4-overexpressing Mesenchymal Stem Cells on Ischemic Heart Injury,” Cell Biochemistry and Function 35, no. 2 (2017): 113-123.

[257] H. Tsai, Y. Wu, X. Liu, et al., “Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection,” Advanced science (Weinheim) 9, no. 3 (2022): e2102634.

[258] O. Bergmann, S. Zdunek, A. Felker, et al., “Dynamics of Cell Generation and Turnover in the Human Heart,” Cell 161, no. 7 (2015): 1566-1575.

[259] K. Kikuchi, J. E. Holdway, A. A. Werdich, et al., “Primary Contribution to Zebrafish Heart Regeneration by gata4(+) Cardiomyocytes,” Nature 464, no. 7288 (2010): 601-605.

[260] Y. Chen, F. F. Luttmann, E. Schoger, et al., “Reversible Reprogramming of Cardiomyocytes to a Fetal state Drives Heart Regeneration in Mice,” Science 373, no. 6562 (2021): 1537-1540.

[261] M. S. Allemann, P. Lee, J. H. Beer, and S. S. Saeedi, “Targeting the Redox System for Cardiovascular Regeneration in Aging,” Aging Cell 22, no. 12 (2023): e14020.

[262] W. Kimura, Y. Nakada, and H. A. Sadek, “Hypoxia-induced Myocardial Regeneration,” Journal of Applied Physiology (1985) 123, no. 6 (2017): 1676-1681.

[263] K. Hirose, A. Y. Payumo, S. Cutie, et al., “Evidence for Hormonal Control of Heart Regenerative Capacity During Endothermy Acquisition,” Science 364, no. 6436 (2019): 184-188.

[264] N. N. Chattergoon, S. Louey, T. Scanlan, et al., “Thyroid Hormone Receptor Function in Maturing Ovine Cardiomyocytes,” The Journal of Physiology 597, no. 8 (2019): 2163-2176.

[265] D. J. Lenihan, S. A. Anderson, C. G. Lenneman, et al., “A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1beta3) in Patients with Systolic Dysfunction and Heart Failure,” JACC: Basic to Translational Science 1, no. 7 (2016): 576-586.

[266] F. Hubert, S. M. Payan, E. Pelce, et al., “FGF10 promotes Cardiac Repair Through a Dual Cellular Mechanism Increasing Cardiomyocyte Renewal and Inhibiting Fibrosis,” Cardiovascular Research 118, no. 12 (2022): 2625-2637.

[267] A. I. Mahmoud, F. Kocabas, S. A. Muralidhar, et al., “Meis1 regulates Postnatal Cardiomyocyte Cell Cycle Arrest,” Nature 497, no. 7448 (2013): 249-253.

[268] N. Nguyen, D. C. Canseco, F. Xiao, et al., “A Calcineurin-Hoxb13 Axis Regulates Growth Mode of Mammalian Cardiomyocytes,” Nature 582, no. 7811 (2020): 271-276.

[269] N. Abbas, F. Perbellini, and T. Thum, “Non-coding RNAs: Emerging Players in Cardiomyocyte Proliferation and Cardiac Regeneration,” Basic Research in Cardiology 115, no. 5 (2020): 52.

[270] L. Sun, Y. Zhang, Y. Zhang, et al., “Expression Profile of Long Non-coding RNAs in a Mouse Model of Cardiac Hypertrophy,” International Journal of Cardiology 177, no. 1 (2014): 73-75.

[271] E. R. Porrello, B. A. Johnson, A. B. Aurora, et al., “MiR-15 family Regulates Postnatal Mitotic Arrest of Cardiomyocytes,” Circulation Research 109, no. 6 (2011): 670-679.

[272] E. R. Porrello, A. I. Mahmoud, E. Simpson, et al., “Regulation of Neonatal and Adult Mammalian Heart Regeneration by the miR-15 family,” PNAS 110, no. 1 (2013): 187-192.

[273] J. Chen, Z. P. Huang, H. Y. Seok, et al., “mir-17-92 Cluster Is Required for and Sufficient to Induce Cardiomyocyte Proliferation in Postnatal and Adult Hearts,” Circulation Research 112, no. 12 (2013): 1557-1566.

[274] F. Gao, M. Kataoka, N. Liu, et al., “Therapeutic Role of miR-19a/19b in Cardiac Regeneration and Protection From Myocardial Infarction,” Nature Communications 10, no. 1 (2019): 1802.

[275] B. Cai, W. Ma, F. Ding, et al., “The Long Noncoding RNA CAREL Controls Cardiac Regeneration,” Journal of the American College of Cardiology 72, no. 5 (2018): 534-550.

[276] G. Chen, H. Li, X. Li, et al., “Loss of Long Non-coding RNA CRRL Promotes Cardiomyocyte Regeneration and Improves Cardiac Repair by Functioning as a Competing Endogenous RNA,” Journal of Molecular and Cellular Cardiology 122 (2018): 152-164.

[277] X. Li, X. He, H. Wang, et al., “Loss of AZIN2 Splice Variant Facilitates Endogenous Cardiac Regeneration,” Cardiovascular Research 114, no. 12 (2018): 1642-1655.

[278] W. Fu, H. Ren, J. Shou, et al., “Loss of NPPA-AS1 Promotes Heart Regeneration by Stabilizing SFPQ-NONO Heteromer-induced DNA Repair,” Basic Research in Cardiology 117, no. 1 (2022): 10.

[279] Y. Chen, X. Li, B. Li, et al., “Long Non-coding RNA ECRAR Triggers Post-natal Myocardial Regeneration by Activating ERK1/2 Signaling,” Molecular Therapy 27, no. 1 (2019): 29-45.

[280] B. Li, Y. Hu, X. Li, et al., “Sirt1 Antisense Long Noncoding RNA Promotes Cardiomyocyte Proliferation by Enhancing the Stability of Sirt1,” Journal of the American Heart Association 7, no. 21 (2018): e009700.

[281] S. Huang, X. Li, H. Zheng, et al., “Loss of Super-Enhancer-Regulated circRNA Nfix Induces Cardiac Regeneration after Myocardial Infarction in Adult Mice,” Circulation 139, no. 25 (2019): 2857-2876.

[282] L. Song, W. Yan, X. Chen, et al., “Myocardial smad4 Is Essential for Cardiogenesis in Mouse Embryos,” Circulation Research 101, no. 3 (2007): 277-285.

[283] H. Zheng, S. Huang, G. Wei, et al., “CircRNA Samd4 Induces Cardiac Repair After Myocardial Infarction by Blocking Mitochondria-derived ROS Output,” Molecular Therapy 30, no. 11 (2022): 3477-3498.

[284] S. Huang, Y. Zhou, Y. Zhang, et al., “Advances in MicroRNA Therapy for Heart Failure: Clinical Trials, Preclinical Studies, and Controversies,” Cardiovascular Drugs and Therapy 39, no. 1 (2025): 221-232.

[285] B. I. Jugdutt, “Ventricular Remodeling After Infarction and the Extracellular Collagen Matrix: When Is Enough Enough?,” Circulation 108, no. 11 (2003): 1395-1403.

[286] M. Ieda, J. D. Fu, P. Delgado-Olguin, et al., “Direct Reprogramming of Fibroblasts Into Functional Cardiomyocytes by Defined Factors,” Cell 142, no. 3 (2010): 375-386.

[287] K. Song, Y. J. Nam, X. Luo, et al., “Heart Repair by Reprogramming Non-myocytes With Cardiac Transcription Factors,” Nature 485, no. 7400 (2012): 599-604.

[288] T. M. Jayawardena, E. A. Finch, L. Zhang, et al., “MicroRNA Induced Cardiac Reprogramming in Vivo: Evidence for Mature Cardiac Myocytes and Improved Cardiac Function,” Circulation Research 116, no. 3 (2015): 418-424.

[289] P. A. Lalit, M. R. Salick, D. O. Nelson, et al., “Lineage Reprogramming of Fibroblasts Into Proliferative Induced Cardiac Progenitor Cells by Defined Factors,” Cell Stem Cell 18, no. 3 (2016): 354-367.

[290] L. Wang, H. Ma, P. Huang, et al., “Down-regulation of Beclin1 Promotes Direct Cardiac Reprogramming,” Science Translational Medicine 12, no. 566 (2020): eaay7856.

[291] Y. Chang, E. Lee, J. Kim, et al., “Efficient in Vivo Direct Conversion of Fibroblasts Into Cardiomyocytes Using a Nanoparticle-based Gene Carrier,” Biomaterials 192 (2019): 500-509.

[292] B. Hu, S. Lelek, B. Spanjaard, et al., “Origin and Function of Activated Fibroblast States During Zebrafish Heart Regeneration,” Nature Genetics 54, no. 8 (2022): 1227-1237.

[293] Y. Wang, Y. Li, J. Feng, et al., “Mydgf Promotes Cardiomyocyte Proliferation and Neonatal Heart Regeneration,” Theranostics 10, no. 20 (2020): 9100-9112.

[294] S. Zhang, X. Zhu, Y. Chen, et al., “The Role and Therapeutic Potential of Macrophages in the Pathogenesis of Diabetic Cardiomyopathy,” Frontiers in immunology 15 (2024): 1393392.

[295] Y. Kim, S. Nurakhayev, A. Nurkesh, Z. Zharkinbekov, and A. Saparov, “Macrophage Polarization in Cardiac Tissue Repair Following Myocardial Infarction,” International Journal of Molecular Sciences 22, no. 5 (2021): 2715.

[296] C. Long, R. Guo, R. Han, et al., “Effects of Macrophages on the Proliferation and Cardiac Differentiation of human Induced Pluripotent Stem Cells,” Cell Communication and Signaling 20, no. 1 (2022): 108.

[297] V. Romano, I. Belviso, A. M. Sacco, et al., “Human Cardiac Progenitor Cell-Derived Extracellular Vesicles Exhibit Promising Potential for Supporting Cardiac Repair in Vitro,” Frontiers in Physiology 13 (2022): 879046.

[298] G. Testa, G. Di Benedetto, and F. Passaro, “Advanced Technologies to Target Cardiac Cell Fate Plasticity for Heart Regeneration,” International Journal of Molecular Sciences 22, no. 17 (2021): 9517.

[299] L. He and X. Chen, “Cardiomyocyte Induction and Regeneration for Myocardial Infarction Treatment: Cell Sources and Administration Strategies,” Advanced Healthcare Materials 9, no. 22 (2020): e2001175.

[300] S. Femmino, F. Bonelli, and M. F. Brizzi, “Extracellular Vesicles in Cardiac Repair and Regeneration: Beyond Stem-cell-based Approaches,” Frontiers in Cell and Developmental Biology 10 (2022): 996887.

[301] C. Bang and T. Thum, “Exosomes: New Players in Cell-cell Communication,” International Journal of Biochemistry & Cell Biology 44, no. 11 (2012): 2060-2064.

[302] L. Gao, L. Wang, Y. Wei, et al., “Exosomes Secreted by hiPSC-derived Cardiac Cells Improve Recovery From Myocardial Infarction in swine,” Science Translational Medicine 12, no. 561 (2020): eaay1318.

[303] G. Wei, C. Li, X. Jia, et al., “Extracellular Vesicle-derived CircWhsc1 Promotes Cardiomyocyte Proliferation and Heart Repair by Activating TRIM59/STAT3/Cyclin B2 Pathway,” Journal of Advanced Research 53 (2023): 199-218.

[304] T. J. Antes, R. C. Middleton, K. M. Luther, et al., “Targeting Extracellular Vesicles to Injured Tissue Using Membrane Cloaking and Surface Display,” Journal of Nanobiotechnology 16, no. 1 (2018): 61.

[305] X. Wang, Y. Chen, Z. Zhao, et al., “Engineered Exosomes with Ischemic Myocardium-Targeting Peptide for Targeted Therapy in Myocardial Infarction,” Journal of the American Heart Association 7, no. 15 (2018): e008737.

[306] Z. Wei, Z. Chen, Y. Zhao, et al., “Mononuclear Phagocyte System Blockade Using Extracellular Vesicles Modified With CD47 on Membrane Surface for Myocardial Infarction Reperfusion Injury Treatment,” Biomaterials 275 (2021): 121000.

[307] B. Liu, B. W. Lee, K. Nakanishi, et al., “Cardiac Recovery via Extended Cell-free Delivery of Extracellular Vesicles Secreted by Cardiomyocytes Derived From Induced Pluripotent Stem Cells,” Nature Biomedical Engineering 2, no. 5 (2018): 293-303.

[308] C. Liu, N. Bayado, D. He, et al., “Therapeutic Applications of Extracellular Vesicles for Myocardial Repair,” Frontiers in Cardiovascular Medicine 8 (2021): 758050.

[309] C. Zhang, H. Hao, Y. Wang, et al., “Intercellular Mitochondrial Component Transfer Triggers Ischemic Cardiac Fibrosis,” Science Bulletin (Beijing) 68, no. 16 (2023): 1784-1799.

[310] M. P. Lutolf and J. A. Hubbell, “Synthetic Biomaterials as Instructive Extracellular Microenvironments for Morphogenesis in Tissue Engineering,” Nature Biotechnology 23, no. 1 (2005): 47-55.

[311] S. Vasu, J. Zhou, J. Chen, P. V. Johnston, and D. H. Kim, “Biomaterials-based Approaches for Cardiac Regeneration,” Korean Circulation Journal 51, no. 12 (2021): 943-960.

[312] Q. L. Wang, H. J. Wang, Z. H. Li, et al., “Mesenchymal Stem Cell-loaded Cardiac Patch Promotes Epicardial Activation and Repair of the Infarcted Myocardium,” Journal of Cellular and Molecular Medicine 21, no. 9 (2017): 1751-1766.

[313] L. Gao, M. E. Kupfer, J. P. Jung, et al., “Myocardial Tissue Engineering with Cells Derived from Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold,” Circulation Research 120, no. 8 (2017): 1318-1325.

[314] L. Ye, Y. H. Chang, Q. Xiong, et al., “Cardiac Repair in a Porcine Model of Acute Myocardial Infarction With human Induced Pluripotent Stem Cell-derived Cardiovascular Cells,” Cell Stem Cell 15, no. 6 (2014): 750-761.

[315] E. Querdel, M. Reinsch, L. Castro, et al., “Human Engineered Heart Tissue Patches Remuscularize the Injured Heart in a Dose-Dependent Manner,” Circulation 143, no. 20 (2021): 1991-2006.

[316] H. S. O'Neill, J. O'Sullivan, N. Porteous, et al., “A Collagen Cardiac Patch Incorporating Alginate Microparticles Permits the Controlled Release of Hepatocyte Growth Factor and Insulin-Like Growth Factor-1 to Enhance Cardiac Stem Cell Migration and Proliferation,” Journal of Tissue Engineering and Regenerative Medicine 12, no. 1 (2018): e384-e394.

[317] M. Li, Y. Liu, B. Huang, et al., “A Self-Homing and Traceable Cardiac Patch Leveraging Ferumoxytol for Spatiotemporal Therapeutic Delivery,” ACS Nano 18, no. 4 (2024): 3073-3086.

[318] C. Ding, G. Tang, Y. Sun, et al., “A Functional Cardiac Patch Promotes Cardiac Repair by Modulating the CCR2(-) Cardiac-resident Macrophage Niche and Their Cell Crosstalk,” Cell Reports Medicine 6, no. 2 (2025): 101932.

[319] Z. Qian, D. Sharma, W. Jia, et al., “Engineering Stem Cell Cardiac Patch With Microvascular Features Representative of Native Myocardium,” Theranostics 9, no. 8 (2019): 2143-2157.

[320] G. W. Ashley, J. Henise, R. Reid, and D. V. Santi, “Hydrogel Drug Delivery System With Predictable and Tunable Drug Release and Degradation Rates,” PNAS 110, no. 6 (2013): 2318-2323.

[321] N. Mamidi, D. R. Velasco, and E. V. Barrera, “Covalently Functionalized Carbon Nano-Onions Integrated Gelatin Methacryloyl Nanocomposite Hydrogel Containing Gamma-Cyclodextrin as Drug Carrier for High-Performance pH-Triggered Drug Release,” Pharmaceuticals (Basel) 14, no. 4 (2021): 291.

[322] C. Zhang, Y. Zhou, H. Han, et al., “Dopamine-Triggered Hydrogels With High Transparency, Self-Adhesion, and Thermoresponse as Skinlike Sensors,” ACS Nano 15, no. 1 (2021): 1785-1794.

[323] Y. Wang, Y. Zhu, Y. Hu, et al., “How to Construct DNA Hydrogels for Environmental Applications: Advanced Water Treatment and Environmental Analysis,” Small 14, no. 17 (2018): e1703305.

[324] P. Li, J. Hu, J. Wang, et al., “The Role of Hydrogel in Cardiac Repair and Regeneration for Myocardial Infarction: Recent Advances and Future Perspectives,” Bioengineering (Basel) 10, no. 2 (2023): 165.

[325] Y. Bingcheng, Y. Xu, W. Xiaoyu, et al., “Overview of Injectable Hydrogels for the Treatment of Myocardial Infarction,” Cardiovascular Innovations and Applications 9 (2024).

[326] Y. Liu, X. Zhang, T. Wu, et al., “Chinese Herb-crosslinked Hydrogel Bearing rBMSCs-laden Polyzwitterion Microgels: Self-adaptive Manipulation of Micromilieu and Stemness Maintenance for Restoring Infarcted Myocardium,” Nano Today 41 (2021): 101306.

[327] P. Chen, W. Zhang, X. Fan, et al., “A Polyphenol-derived Redox-active and Conductive Nanoparticle-reinforced Hydrogel With Wet Adhesiveness for Myocardial Infarction Repair by Simultaneously Stimulating Anti-inflammation and Calcium Homeostasis Pathways,” Nano Today 55 (2024): 102157.

[328] A. Hasan, A. Khattab, M. A. Islam, et al., “Injectable Hydrogels for Cardiac Tissue Repair After Myocardial Infarction,” Advanced science (Weinheim) 2, no. 11 (2015): 1500122.

[329] S. McLaughlin, B. McNeill, J. Podrebarac, et al., “Injectable human Recombinant Collagen Matrices Limit Adverse Remodeling and Improve Cardiac Function After Myocardial Infarction,” Nature Communications 10, no. 1 (2019): 4866.

[330] R. Dimatteo, N. J. Darling, and T. Segura, “In Situ Forming Injectable Hydrogels for Drug Delivery and Wound Repair,” Advanced Drug Delivery Reviews 127 (2018): 167-184.

[331] P. Contessotto, D. Orbanic, C. M. Da, et al., “Elastin-Like Recombinamers-based Hydrogel Modulates Post-ischemic Remodeling in a Non-transmural Myocardial Infarction in Sheep,” Science Translational Medicine 13, no. 581 (2021): eaaz5380.

[332] C. Hu, W. Liu, L. Long, et al., “Regeneration of Infarcted Hearts by Myocardial Infarction-responsive Injectable Hydrogels With Combined Anti-apoptosis, Anti-inflammatory and Pro-angiogenesis Properties,” Biomaterials 290 (2022): 121849.

[333] B. Wang, R. J. Lee, and L. Tao, “First-in-human Transcatheter Endocardial Alginate-hydrogel Implantation for the Treatment of Heart Failure,” European Heart Journal 44, no. 4 (2023): 326.

[334] M. Lunova, B. Smolkova, M. Uzhytchak, et al., “Light-induced Modulation of the Mitochondrial respiratory Chain Activity: Possibilities and Limitations,” Cellular and Molecular Life Sciences 77, no. 14 (2020): 2815-2838.

[335] W. Ong, H. Chen, C. Tsai, et al., “The Activation of Directional Stem Cell Motility by Green Light-emitting Diode Irradiation,” Biomaterials 34, no. 8 (2013): 1911-1920.

[336] R. A. Mussttaf, D. F. L. Jenkins, and A. N. Jha, “Assessing the Impact of Low Level Laser Therapy (LLLT) on Biological Systems: A Review,” International Journal of Radiation Biology 95, no. 2 (2019): 120-143.

[337] X. Gao, W. Zhang, F. Yang, W. Ma, and B. Cai, “Photobiomodulation Regulation as One Promising Therapeutic Approach for Myocardial Infarction,” Oxidative Medicine and Cellular Longevity 2021 (2021): 9962922.

[338] T. Yaakobi, Y. Shoshany, S. Levkovitz, et al., “Long-term Effect of Low Energy Laser Irradiation on Infarction and Reperfusion Injury in the Rat Heart,” Journal of Applied Physiology (1985) 90, no. 6 (2001): 2411-2419.

[339] M. Wang, Z. Xu, Q. Liu, et al., “Nongenetic Optical Modulation of Neural Stem Cell Proliferation and Neuronal/Glial Differentiation,” Biomaterials 225 (2019): 119539.

[340] M. W. Jenkins, A. R. Duke, S. Gu, et al., “Optical Pacing of the Embryonic Heart,” Nature Photonics 4 (2010): 623-626.

[341] X. Gao, H. Li, W. Zhang, et al., “Photobiomodulation Drives MiR-136-5p Expression to Promote Injury Repair After Myocardial Infarction,” International Journal of Biological Sciences 18, no. 7 (2022): 2980-2993.

[342] Y. Liu, D. Zhong, Y. He, et al., “Photoresponsive Hydrogel-Coated Upconversion Cyanobacteria Nanocapsules for Myocardial Infarction Prevention and Treatment,” Advanced science (Weinheim) 9, no. 30 (2022): e2202920.

[343] M. Chaves, A. R. D. Araujo, A. C. C. Piancastelli, and M. Pinotti, “Effects of Low-power Light Therapy on Wound Healing: LASER X LED,” Anais Brasileiros De Dermatologia 89, no. 4 (2014): 616-623.

[344] L. Gepstein, G. Hayam, S. Shpun, and S. A. Ben-Haim, “Hemodynamic Evaluation of the Heart With a Nonfluoroscopic Electromechanical Mapping Technique,” Circulation 96, no. 10 (1997): 3672-3680.

[345] R. Kornowski, M. K. Hong, L. Gepstein, et al., “Preliminary Animal and Clinical Experiences Using an Electromechanical Endocardial Mapping Procedure to Distinguish Infarcted From Healthy Myocardium,” Circulation 98, no. 11 (1998): 1116-1124.

[346] M. C. Lock, J. R. T. Darby, J. Y. Soo, et al., “Differential Response to Injury in Fetal and Adolescent Sheep Hearts in the Immediate Post-myocardial Infarction Period,” Frontiers in Physiology 10 (2019): 208.

[347] J. Sun, L. Wang, R. C. Matthews, et al., “CCND2 Modified mRNA Activates Cell Cycle of Cardiomyocytes in Hearts with Myocardial Infarction in Mice and Pigs,” Circulation Research 133, no. 6 (2023): 484-504.

[348] A. Jebran, T. Seidler, M. Tiburcy, et al., “Engineered Heart Muscle Allografts for Heart Repair in Primates and Humans,” Nature 639, no. 8054 (2025): 503-511.

[349] L. Li, M. Lu, L. Guo, et al., “An Organ-wide Spatiotemporal Transcriptomic and Cellular Atlas of the Regenerating Zebrafish Heart,” Nature Communications 16, no. 1 (2025): 3716.

[350] D. Cai, C. Liu, H. Li, et al., “Foxk1 and Foxk2 Promote Cardiomyocyte Proliferation and Heart Regeneration,” Nature Communications 16, no. 1 (2025): 2877.

[351] C. V. Theodoris, P. Zhou, L. Liu, et al., “Network-based Screen in iPSC-derived Cells Reveals Therapeutic Candidate for Heart Valve Disease,” Science 371, no. 6530 (2021): eabd0724.

[352] S. Sokmen, S. Cakmak, and I. Oksuz, “3D printing of an Artificial Intelligence-generated Patient-specific Coronary Artery Segmentation in a Support Bath,” Biomedical Materials 19, no. 3 (2024).

[353] V. Sedlakova, C. McTiernan, D. Cortes, E. J. Suuronen, and E. I. Alarcon, “3D Bioprinted Cardiac Tissues and Devices for Tissue Maturation,” Cells Tissues Organs 211, no. 4 (2022): 406-419.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.